Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
49
CNXC Quote, Financials, Valuation and Earnings
Last price:
$41.66
Seasonality move
:
4.76%
Day range:
$40.20 - $41.79
52-week range:
$31.63 - $66.00
Dividend yield:
3.26%
P/E ratio:
8.81x
P/S ratio:
0.27x
P/B ratio:
0.60x
Volume:
550.8K
Avg. volume:
1.1M
1-year change:
-3.05%
Market cap:
$2.6B
Revenue:
$9.6B
EPS (TTM):
$4.73
Analysts' Opinion
-
Consensus RatingConcentrix Corp. has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 2 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $63.60, Concentrix Corp. has an estimated upside of 52.56% from its current price of $41.69.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $54.00 representing 100% downside risk from its current price of $41.69.
Fair Value
-
According to the consensus of 4 analysts, Concentrix Corp. has 52.56% upside to fair value with a price target of $63.60 per share.
CNXC vs. S&P 500
-
Over the past 5 trading days, Concentrix Corp. has overperformed the S&P 500 by 2.78% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Concentrix Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Concentrix Corp. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Concentrix Corp. reported revenues of $2.5B.
Earnings Growth
-
Concentrix Corp. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Concentrix Corp. reported earnings per share of $1.34.
Enterprise value:
7.8B
EV / Invested capital:
--
Price / LTM sales:
0.27x
EV / EBIT:
10.68x
EV / Revenue:
0.80x
PEG ratio (5yr expected):
0.17x
EV / Free cash flow:
15.07x
Price / Operating cash flow:
5.14x
Enterprise value / EBITDA:
5.60x
Gross Profit (TTM):
$2.8B
Return On Assets:
2.48%
Net Income Margin (TTM):
3.1%
Return On Equity:
7.22%
Return On Invested Capital:
3.05%
Operating Margin:
6.64%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-08-31 | 2024-08-31 | 2025-08-31 | 2024-08-31 | 2025-08-31 | |
| Income Statement | ||||||
| Revenue | $6.5B | $9.4B | $9.7B | $2.4B | $2.5B | |
| Gross Profit | $2.1B | $2.7B | $2.8B | $690.6M | $685.9M | |
| Operating Income | $743.8M | $775.8M | $728.4M | $192.4M | $164.9M | |
| EBITDA | $1.1B | $1.5B | $1.4B | $368.5M | $333.4M | |
| Diluted EPS | $6.68 | $3.09 | $4.73 | $0.25 | $1.34 | |
| Period Ending | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | 2025-08-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.5B | $1.7B | $3.7B | $2.9B | $3.1B | |
| Total Assets | $5B | $6.7B | $8.4B | $12.2B | $12.4B | |
| Current Liabilities | $888.8M | $1B | $1B | $1.8B | $2B | |
| Total Liabilities | $2.4B | $4.1B | $5.5B | $8B | $8.1B | |
| Total Equity | $2.6B | $2.6B | $2.9B | $4.2B | $4.3B | |
| Total Debt | $1.2B | $2.8B | $4.3B | $5.5B | $5.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-08-31 | 2024-08-31 | 2025-08-31 | 2024-08-31 | 2025-08-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $684.4M | $612.4M | $747.1M | $191.6M | $224.8M | |
| Cash From Investing | -$153.8M | -$2.2B | -$233M | -$62.7M | -$65.1M | |
| Cash From Financing | $1.4B | -$101.7M | -$435.9M | -$84.8M | -$164.8M | |
| Free Cash Flow | $526M | $368.6M | $515.8M | $128.9M | $159.7M | |
CNXC
Sector
Market Cap
$2.6B
$486.6M
Price % of 52-Week High
63.17%
80.87%
Dividend Yield
3.26%
0%
Shareholder Yield
7.82%
1.54%
1-Year Price Total Return
-3.05%
--
Beta (5-Year)
0.551
0.550
Dividend yield:
3.26%
Annualized payout:
$1.24
Payout ratio:
24.87%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$40.34
200-day SMA
Sell
Level
$48.97
Bollinger Bands (100)
Sell
Level
38.01 - 51.49
Chaikin Money Flow
Sell
Level
-19.1M
20-day SMA
Buy
Level
$38.65
Relative Strength Index (RSI14)
Buy
Level
64.00
ADX Line
Buy
Level
21.42
Williams %R
Sell
Level
-6.3304
50-day SMA
Buy
Level
$39.18
MACD (12, 26)
Buy
Level
0.77
25-day Aroon Oscillator
Buy
Level
88
On Balance Volume
Sell
Level
-25.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.4525)
Sell
CA Score
(Annual)
Level (-0.6386)
Buy
Beneish M-Score
(Annual)
Level (-2.5811)
Buy
Momentum Score
Level (5)
Sell
Ohlson Score
Level (0.4542)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Concentrix Corp. engages in the provision of customer experience solutions and technology. The company was founded in 1973 and is headquartered in Newark, CA.
Stock Forecast FAQ
In the current month, CNXC has received 2 Buy ratings 2 Hold ratings, and 0 Sell ratings. The CNXC average analyst price target in the past 3 months is $63.60.
-
Where Will Concentrix Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Concentrix Corp. share price will rise to $63.60 per share over the next 12 months.
-
What Do Analysts Say About Concentrix Corp.?
Analysts are divided on their view about Concentrix Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Concentrix Corp. is a Sell and believe this share price will drop from its current level to $54.00.
-
What Is Concentrix Corp.'s Price Target?
The price target for Concentrix Corp. over the next 1-year time period is forecast to be $63.60 according to 4 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is CNXC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Concentrix Corp. is a Leans Bullish. 2 of 4 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of CNXC?
You can purchase shares of Concentrix Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Concentrix Corp. shares.
-
What Is The Concentrix Corp. Share Price Today?
Concentrix Corp. was last trading at $41.66 per share. This represents the most recent stock quote for Concentrix Corp.. Yesterday, Concentrix Corp. closed at $41.69 per share.
-
How To Buy Concentrix Corp. Stock Online?
In order to purchase Concentrix Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get CNXC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CNXC
Sector
P/E ratio
8.81x
19.19x
PEG ratio
0.17x
0.18x
P/B ratio
0.60x
1.70x
Price / LTM sales
0.27x
0.85x
Growth Metrics
CNXC
Sector
Revenue growth
4.01%
5.02%
Earnings growth
439.08%
5.76%
Revenue (5-year growth)
15.36%
4.27%
Earnings forecast
$2.91
$0.39
Profitability
CNXC
Sector
Profitability FY 2024
$2.7B
$253.7M
Return on invested capital
3.05%
4.73%
Return on assets
2.48%
3.1%
Return on equity
7.22%
8.11%
Earnings Date
Last Earnings Date
Sep
25
Next Earnings Date
Jan
13
Estimated Next Earnings Date
Dec
25
Balance Sheet
CNXC
Sector
Total cash
$538.5M
$139M
Short term investments
--
$32.7M
Total assets
$12B
$1.4B
Long term debt
$5.5B
$51.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
87
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
60
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
